Ivan Borbath

Ivan Borbath

Université Catholique de Louvain - Louvain-la-Neuve / Belgium
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 1398871
Catholic University of Louvain
person_outline Ivan Borbath's MOST POPULAR ARTICLES
1-) Sorafenib in advanced hepatocellular carcinomaJM Llovet, S Ricci, V Mazzaferro, P Hilgard, E Gane, JF Blanc, ...New England journal of medicine 359 (4), 378-390, 2008131752008
2-) Sunitinib malate for the treatment of pancreatic neuroendocrine tumorsE Raymond, L Dahan, JL Raoul, YJ Bang, I Borbath, C Lombard-Bohas, ...New England Journal of Medicine 364 (6), 501-513, 201126892011
3-) Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trialAX Zhu, RS Finn, J Edeline, S Cattan, S Ogasawara, D Palmer, ...The Lancet Oncology 19 (7), 940-952, 201815562018
4-) Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib …P Hammel, F Huguet, JL van Laethem, D Goldstein, B Glimelius, P Artru, ...Jama 315 (17), 1844-1853, 201611132016
5-) Phase II study of BGJ398 in patients with FGFR-altered advanced cholangiocarcinomaM Javle, M Lowery, RT Shroff, KH Weiss, C Springfeld, MJ Borad, ...Journal of Clinical Oncology 36 (3), 276-282, 20187112018